|

Mepolizumab Clinical Trials

3 actively recruiting trials

Also known as: Dupilumab, Omalizumab, nucala

Pipeline

Phase 4: 1

Top Sponsors

  • University Hospital, Ghent1
  • St. Paul's Sinus Centre1
  • Laval University1

Indications

  • Asthma3
  • Chronic Rhinosinusitis With Nasal Polyps2
  • Chronic Rhinosinusitis Without Nasal Polyps1

Other3 trials

Comparison of Immune Profiles in Chronic Rhinosinusitis Patients After Mepolizumab Treatment
Phase 4
Real Life Study of Biologicals in Patients With Severe CRSwNP
Residual Exacerbations With Mepolizumab

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.